Mortality of hepatitis B surface antigen-positive blood donors in England and Wales

International Journal of Epidemiology - Tập 32 Số 1 - Trang 118-124 - 2003
Paul Crook1, Michael E. Jones, Andrew Hall
1#N# #N# London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Van DP, Vellinga A. Epidemiology of hepatitis B and C in Europe. Acta Gastroenterol Belg1998;61:175–82.

International Agency for Research on Cancer. Hepatitis Viruses. Lyon: International Agency for Research on Cancer, 2001.

Beasley RP, Hwang LY. Overview on the epidemiology of hepatocellular carcinoma. In: Hollinger FB (ed.). Viral Hepatitis & Liver Disease. Baltimore: Williams and Wilkins, 1991, pp. 532–35.

Beasley RP, Lin CC. Hepatoma risk among HBsAg carriers. Am J Epidemiol1978;108:247.

Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet1981;ii:1129–33.

Nomura A, Stemmermann GN, Wasnich RD. Presence of hepatitis B surface antigen before primary hepatocellular carcinoma. JAMA1982; 247:2247–49.

McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med1990; 150:1051–54.

Fukao A. An epidemiological study on relationship between hepatitis B virus and hepatocellular carcinoma. Nippon Shokakibyo Gakkai Zasshi1985;82:232–38.

Tu JT, Gao RN, Zhang DH, Gu BC. Hepatitis B virus and primary liver cancer on Chongming Island, People’s Republic of China. Natl Cancer Inst Monogr1985;69:213–15.

Ding ZG. Epidemiological study on relationship between hepatitis B and liver cancer—a prospective study on development of liver cancer and distribution of HBsAg carriers and liver damage persons in Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi1988;9:220–23.

Sakuma K, Saitoh N, Kasai M et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology1988;8:1642–46.

Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res1989;49:2506–09.

Mori M, Hara M, Wada I et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol2000;151:131–39.

Prince AM, Alcabes P. The risk of development of hepatocellular carcinoma in hepatitis B virus carriers in New York. A preliminary estimate using death-records matching. Hepatology1982;2:15S–20S.

Dodd RY, Nath N. Increased risk for lethal forms of liver disease among HBsAg-positive blood donors in the United States. J Virol Methods1987;17:81–94.

Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer1984;34:775–79.

Tokudome S, Ikeda M, Matsushita K, Maeda Y, Yoshinari M. Hepatocellular carcinoma among female Japanese hepatitis B virus carriers. Hepatogastroenterology1987;34:246–48.

Hall AJ, Winter PD, Wright R. Mortality of hepatitis B positive blood donors in England and Wales. Lancet1985;i:91–93.

Dragosics B, Ferenci P, Hitchman E, Denk H. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology1987;7:302–06.

Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology1995;22:432–38.

Ross RK et al. Urinary aflatoxin biomarkers and risks of hepatocellular carcinoma. Lancet1992;339:943–46.

London WT, Evans AA, Buetow K et al. Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal. Princess Takamatsu Symp1995;25:51–60.

Office of Population Censuses and Surveys. Comparison of the 8th and 9th International Classification of Diseases. Incorporating short list bridge-coding, 1978 (a sample) for England & Wales. 1978:

Coleman M, Douglas A, Hermon C, Peto J. Cohort study analysis with a FORTRAN computer program. Int J Epidemiol1986;15:134–37.

Monson RR. Occupational Epidemiology. Boca Raton, FL: CRC Press, 1980, pp. 54–59.

Sobeslavsky O. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study. Bull World Health Organ1980;58:621–28.

Sampliner RE. The duration of hepatitis B surface antigenemia. Arch Intern Med1979;139:145–46.